Additional file 5: Table S5. of Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer
Year: 2016
Type: dataset
Abstract: Gene expression values for all treatment cohorts expressed as relative fold-change compared to control. (XLSX 623Â kb)
Source: Figshare
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4394540138
